Document is current
Any future updates will be listed below
-
Authors
Wang, Zimeng https://orcid.org/0009-0003-2626-3255
Cheng, Bei https://orcid.org/0000-0002-3302-8267
Tkaczyk, Christine https://orcid.org/0000-0002-3346-8131
Newton, Michael https://orcid.org/0000-0003-4979-1475
Cui, Shuolin https://orcid.org/0000-0002-2774-3969
Andreiuk, Bohdan https://orcid.org/0000-0001-6844-5733
Saha, Sanjib https://orcid.org/0000-0003-1534-7130
Khan, Sabrina
Chen, Charles https://orcid.org/0000-0001-7695-5215
Yang, Bin
Gamson, Adam
Siddiqui, Sarah
Thom, George
DiGiandomenico, Antonio https://orcid.org/0000-0003-1745-647X
Zhou, Liping https://orcid.org/0000-0003-2353-6134
-
Funding
Funding for this research was provided by:
Defense Advanced Research Projects Agency (HR011-18-3-001)
- License Information
-
More Information
Article History
Received: 30 September 2025
Accepted: 23 January 2026
First Online: 23 March 2026
Declarations
:
: All authors were at the time of the study employees of AstraZeneca and may hold shares in AstraZeneca. The authors declare no competing interests.
